COMMUNIQUÉS West-GlobeNewswire

iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer
03/07/2018
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer Gosselies, Belgium – July 3, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announced the [...]
Lexington Biosciences Announces Results of Annual General Meeting
03/07/2018
VANCOUVER, British Columbia, July 02, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, wishes to provide the [...]
Optinose Named a 2018 Best Place to Work by Philadelphia Business Journal
02/07/2018
YARDLEY, Pa., July 02, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the Company has [...]
Acasti Pharma Announces Annual Performance Grants of Stock Options, Amendment of Stock Option Plan and Issuance of Common Shares in Payment of Outstanding Interest under Debentures
02/07/2018
LAVAL, Québec, July 02, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ:ACST) (TSX-V:ACST), today announced the grant of stock options to its employees, executives and directors, and that [...]
Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Closing of Initial Public Offering and the Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
02/07/2018
MALVERN, Pa., July 02, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc., a commercial-stage medical device company focused on designing, developing, and manufacturing products that improve the quality of life for patients who [...]
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02/07/2018
EMERYVILLE, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]
HMS Settles Litigation Related To 2010 Asset Purchase - Agreement Substantially Reduces 2017 Jury Award
02/07/2018
IRVING, Texas, July 02, 2018 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (Nasdaq:HMSY) today announced that it has reached a settlement agreement in litigation pending in the Supreme Court of New York. The case related to [...]
Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
02/07/2018
SAN DIEGO, July 02, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced the closing of [...]
NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018
02/07/2018
FT. MYERS, Fla., July 02, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its second quarter 2018 [...]
Zafgen Announces Closing of Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Common Shares
02/07/2018
BOSTON, July 02, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary MetAP2 biology platform to develop novel therapies for patients affected by [...]
TiGenix: Transparency Information
02/07/2018
PRESS RELEASE REGULATED INFORMATION Transparency Information Leuven (Belgium) - July 2, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 of [...]
Align Technology to Announce Second Quarter 2018 Results on July 25, 2018
02/07/2018
SAN JOSE, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) announced today that the Company will report second quarter 2018 financial results on Wednesday, July 25, 2018 after the close of [...]
OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Early Stage Prostate Cancer
02/07/2018
BATON ROUGE, La., July 02, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Summit Therapeutics plc : Holding(s) in Company
02/07/2018
TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : SUMMIT THERAPEUTICS PLC 1b. Please indicate if the [...]
Summit Therapeutics plc : Holding(s) in Company
02/07/2018
TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : SUMMIT THERAPEUTICS PLC 1b. Please indicate if the [...]
Alzheimer’s Foundation of America Awards College Scholarships to Students Impacted by Alzheimer’s Disease
02/07/2018
NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America recently awarded $30,000 in scholarships to 30 high school students from 25 states across the country who submitted essays for AFA’s [...]
Carp Cosmetic Surgery Center Now Offering CoolSculpting®
02/07/2018
The non-surgical body contouring procedure freezes away unwanted fat cells AKRON, Ohio, July 02, 2018 (GLOBE NEWSWIRE) -- Steven S. Carp, MD, of Carp Cosmetic Surgery Center offers patients and the community a non- [...]
Sanofi: Disclosure of trading in own shares
02/07/2018
Attachment Disclosure of trading in own shares (PDF).pdf
Sanofi : Déclaration des transactions sur actions propres
02/07/2018
Pièce jointe Déclaration des transactions sur actions propres (PDF).pdf

Pages